Physician

Jeffrey Dwight Upton, MD

According to 2025 Medicare claims, Jeffrey Upton, MD (NPI: 1790744209) practices urology in the Carson City, NV market, with the plurality of this provider's patient population coming from Carson City, NV. This provider's primary affiliated billing organization is CARSON TAHOE PHYSICIAN CLINICS (NPI: 1023265717; TIN: 02-0566741) and primary practice location at 89703-0001. Upton is affiliated with the Silver State ACO LLC (ACO ID: A2251) and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Upton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,281 traditional Medicare patients, billed 6,313 HCPCS/CPT codes, and received $329,178 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 4,491 prescription claims across 1,141 beneficiaries totaling $447,820 in drug costs, led by Gemtesa (Vibegron). DME data shows 112 claims. Open Payments data shows 8 records totaling $146. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,556	5,795	$264,776
2016	1,628	5,655	$261,873
2017	1,643	5,678	$246,849
2018	1,542	5,279	$225,644
2019	1,503	5,208	$248,578
2020	1,403	3,993	$204,620
2021	1,284	3,856	$215,282
2022	1,245	3,833	$203,159
2023	1,108	3,480	$174,200
2024	1,281	6,313	$329,178

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	680	3,669	$358,515
2016	729	3,901	$411,436
2017	758	4,161	$450,456
2018	748	3,999	$416,931
2019	749	3,804	$378,743
2020	768	3,819	$359,936
2021	764	3,807	$339,987
2022	762	3,728	$306,498
2023	748	3,525	$332,825
2024	1,141	4,491	$447,820

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	114	$17,909
2016	17	80	$23,831
2017	13	65	$31,745
2018	N/R	44	$27,707
2019	N/R	43	$27,313
2020	N/R	46	$24,568
2021	N/R	60	$20,194
2022	N/R	70	$36,264
2023	N/R	111	$71,138
2024	16	112	$90,629

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	166	166	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	546	662	$101
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	485	600	$69
51798	Ultrasound measurement of bladder capacity after voiding	233	261	$9
81003	Automated urinalysis test	1,084	1,624	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gemtesa	Vibegron	230	9,823	$153,809
Myrbetriq	Mirabegron	156	7,420	$110,477
Estradiol	Estradiol	331	19,064	$42,234
Yuvafem	Estradiol	212	9,256	$23,944
Tamsulosin Hcl	Tamsulosin Hcl	1,146	84,829	$19,281

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	30	$68,198
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	16	55	$21,456
A4357	Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each	N	N/R	16	$634
A4332	Lubricant, individual sterile packet, each	N	N/R	11	$342

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$146	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jeffrey Dwight Upton, MD?

Tedicare shows public-source Medicare data for Jeffrey Dwight Upton, MD (NPI 1790744209), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey Dwight Upton, MD have ACO affiliation data?

Jeffrey Dwight Upton, MD is shown with ACO affiliation data for Silver State ACO LLC (MSSP, ACO ID A2251) and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Jeffrey Dwight Upton, MD?

Jeffrey Dwight Upton, MD is linked to CARSON TAHOE PHYSICIAN CLINICS (billing NPI 1023265717) in the available physician profile data.

Does Jeffrey Dwight Upton, MD have Open Payments data?

Jeffrey Dwight Upton, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.